|
US5624813A
(en)
|
1994-04-21 |
1997-04-29 |
Mahant; Vijay K. |
NAD(P)+ /NAD(P)H based chemiluminescent diagnostics
|
|
FR2739029B1
(fr)
|
1995-09-21 |
1997-11-21 |
Roussel Uclaf |
Nouvelle application therapeutique des composes antimineralo-corticoides
|
|
WO1997020942A1
(en)
|
1995-12-05 |
1997-06-12 |
Piao Yun Shang |
Hsd17b1 promoter, enhancer, silencer and use thereof
|
|
US6391311B1
(en)
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
|
HUP0101809A3
(en)
|
1998-03-11 |
2002-07-29 |
Endorech Inc Sainte Foy |
Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use
|
|
FR2801218B1
(fr)
|
1999-11-23 |
2001-12-28 |
Hoechst Marion Roussel Inc |
Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
|
|
WO2005014811A2
(en)
*
|
2003-08-08 |
2005-02-17 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20050119211A1
(en)
*
|
2001-05-18 |
2005-06-02 |
Sirna Therapeutics, Inc. |
RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
|
|
US20050182007A1
(en)
*
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
|
WO2003012052A2
(en)
|
2001-07-30 |
2003-02-13 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Specific inhibition of gene expression by small double stranded rnas
|
|
AU2003295600A1
(en)
*
|
2002-11-14 |
2004-06-15 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
|
US7217807B2
(en)
|
2002-11-26 |
2007-05-15 |
Rosetta Genomics Ltd |
Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
|
|
US7754709B2
(en)
|
2003-06-10 |
2010-07-13 |
Solvay Pharmaceuticals Bv |
Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
|
|
US20090169585A1
(en)
|
2003-10-23 |
2009-07-02 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
|
|
US20050158376A1
(en)
|
2003-10-23 |
2005-07-21 |
Sardi William F. |
Dietary supplement and method of processing same
|
|
US20080299042A1
(en)
|
2004-04-30 |
2008-12-04 |
Biogen Idec Ma Inc. |
Membrane Associated Molecules
|
|
US7820380B2
(en)
|
2004-05-07 |
2010-10-26 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis
|
|
US8598333B2
(en)
*
|
2006-05-26 |
2013-12-03 |
Alnylam Pharmaceuticals, Inc. |
SiRNA silencing of genes expressed in cancer
|
|
FR2904000A1
(fr)
|
2006-07-19 |
2008-01-25 |
Galderma Res & Dev S N C Snc |
Modulateurs de hsd17b7 dans le traitement de l'acne ou de l'hyperseborrhee
|
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
|
US20100267052A1
(en)
|
2006-09-01 |
2010-10-21 |
American Type Culture Collection |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
US20080300170A1
(en)
|
2006-09-01 |
2008-12-04 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment for type 2 diabetes
|
|
US20090203602A1
(en)
|
2006-09-01 |
2009-08-13 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
|
WO2008091873A2
(en)
|
2007-01-24 |
2008-07-31 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the identification, assessment, prevention and therapy of thymic lymphoma or hamartomatous tumours
|
|
JP2010505897A
(ja)
*
|
2006-10-11 |
2010-02-25 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
インフルエンザターゲット
|
|
JP2010540444A
(ja)
|
2007-09-20 |
2010-12-24 |
レスベラトロル パートナーズ， エルエルシー |
遺伝子産物の濃縮または活性を調節するためのレスベラトロールを含む組成物
|
|
EP2298359A1
(en)
|
2008-06-04 |
2011-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Nucleic acid capable of controlling degranulation of mast cell
|
|
WO2010028110A2
(en)
|
2008-09-04 |
2010-03-11 |
Board Of Regents, The University Of Texas System |
Sequence variations in pnpla3 associated with hepatic steatosis
|
|
US20100209427A1
(en)
|
2008-09-24 |
2010-08-19 |
Yu Li |
Lysine acetylation sites
|
|
EP2177615A1
(en)
|
2008-10-10 |
2010-04-21 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases
|
|
JPWO2010064702A1
(ja)
|
2008-12-05 |
2012-05-10 |
国立大学法人 東京大学 |
癌の予後を予測するためのバイオマーカー
|
|
CA2697169A1
(en)
|
2009-03-18 |
2010-09-18 |
David Stojdl |
Compositions and methods for augmenting activity of oncolytic viruses
|
|
WO2010120526A2
(en)
|
2009-03-31 |
2010-10-21 |
Emory University |
Methods and systems for screening for and diagnosing dna methylation associated with autism spectrum disorders
|
|
US9051567B2
(en)
|
2009-06-15 |
2015-06-09 |
Tekmira Pharmaceuticals Corporation |
Methods for increasing efficacy of lipid formulated siRNA
|
|
ES2657737T3
(es)
|
2009-07-15 |
2018-03-06 |
Calimmune Inc. |
Vector dual para la inhibición del virus de la inmunodeficiencia humana
|
|
WO2011006214A1
(en)
|
2009-07-16 |
2011-01-20 |
Peter Maccallum Cancer Institute |
Method of detecting radiation exposure and adverse toxicity thereto
|
|
CA2781654A1
(en)
|
2009-11-25 |
2011-06-03 |
Hua Gong |
Novel genomic biomarkers for irritable bowel syndrome diagnosis
|
|
WO2011084747A2
(en)
|
2009-12-21 |
2011-07-14 |
The Johns Hopkins University |
Compositions and methods for somatic tissue induced pluripotent stem cells having an endoderm origin
|
|
US20130029873A1
(en)
|
2010-04-12 |
2013-01-31 |
University Health Network |
Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation
|
|
WO2011128096A1
(en)
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
|
|
DK2569446T3
(en)
|
2010-05-12 |
2018-10-29 |
Steven E Schutzer |
DIAGNOSTIC MARKERS FOR NEUROPsychiatric Disease
|
|
US8945847B2
(en)
|
2010-05-24 |
2015-02-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for ascertaining biosafety of an agent
|
|
US20120058088A1
(en)
|
2010-06-28 |
2012-03-08 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Methods Of Use
|
|
CA2804763C
(en)
|
2010-07-14 |
2023-01-03 |
The Regents Of The University Of California |
Biomarkers for diagnosis of transient ischemic attacks
|
|
WO2012031008A2
(en)
|
2010-08-31 |
2012-03-08 |
The General Hospital Corporation |
Cancer-related biological materials in microvesicles
|
|
WO2012052953A1
(en)
|
2010-10-20 |
2012-04-26 |
Fondazione Centro San Raffaele Del Monte Tabor |
MiRNA
|
|
WO2012058097A1
(en)
|
2010-10-26 |
2012-05-03 |
Buck Institute For Age Research |
Downregulation of sine/alu retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cell
|
|
CA2817256A1
(en)
|
2010-11-12 |
2012-05-18 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
US9920317B2
(en)
|
2010-11-12 |
2018-03-20 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
|
WO2012070014A2
(en)
|
2010-11-26 |
2012-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
|
|
US20140057800A1
(en)
|
2010-12-16 |
2014-02-27 |
Norwegian Univeristy of Science and Technology (NTNU) |
Single nucleotide polymorphism associated with risk of insulin resistance development
|
|
EP2655621B1
(en)
|
2010-12-20 |
2018-05-23 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
WO2012151346A1
(en)
|
2011-05-03 |
2012-11-08 |
Dermachip Inc. |
Expression signatures of genes and gene networks associated with skin aging
|
|
GB201112246D0
(en)
|
2011-07-15 |
2011-08-31 |
Univ Birmingham |
Diagnosis of alzheimer's disease
|
|
US20130079241A1
(en)
|
2011-09-15 |
2013-03-28 |
Jianhua Luo |
Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse
|
|
SI3366775T2
(sl)
|
2011-11-18 |
2025-12-31 |
Alnylam Pharmaceuticals, Inc. |
Modificirana sredstva RNAI
|
|
WO2013126565A1
(en)
|
2012-02-24 |
2013-08-29 |
Lunyak Victoria V |
Downregulation of sine/alu retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cell
|
|
US9133461B2
(en)
|
2012-04-10 |
2015-09-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the ALAS1 gene
|
|
WO2013166264A2
(en)
|
2012-05-02 |
2013-11-07 |
University Of Georgia Research Foundation, Inc. |
Methods for altering virus replication
|
|
US9677138B2
(en)
|
2012-05-20 |
2017-06-13 |
Trustees Of Boston University |
Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease
|
|
AU2013266968B2
(en)
|
2012-05-25 |
2017-06-29 |
Emmanuelle CHARPENTIER |
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
|
|
EP2864791A2
(en)
|
2012-06-20 |
2015-04-29 |
Leibniz - Institut für Analytische Wissenschaften - ISAS - E.V. |
Specific biomarkers for hepatocellular carcinoma (hcc)
|
|
US20140004153A1
(en)
|
2012-07-02 |
2014-01-02 |
Lancell, L.L.C. |
Use of somatic mutations in the extracellular domain of transmembrane proteins in a patient's tumor as immunogens for active humoral immunotherapy of cancer
|
|
WO2014028946A2
(en)
|
2012-08-17 |
2014-02-20 |
The Broad Institute, Inc. |
Modulators of hepatic lipoprotein metabolism
|
|
NZ706067A
(en)
|
2012-09-26 |
2016-07-29 |
Tangent Reprofiling Ltd |
Modulators of androgen synthesis
|
|
US9375433B2
(en)
|
2012-09-26 |
2016-06-28 |
Tangent Reprofiling Limited |
Modulators of androgen synthesis
|
|
IL292159B1
(en)
|
2012-12-05 |
2026-04-01 |
Alnylam Pharmaceuticals Inc |
PCSK9 iRNA compositions and methods of using them
|
|
EP4331620A3
(en)
|
2012-12-07 |
2024-12-04 |
Translate Bio, Inc. |
Lipidic nanoparticles for mrna delivery
|
|
US20160032395A1
(en)
|
2013-03-14 |
2016-02-04 |
Elai Davicioni |
Cancer biomarkers and classifiers and uses thereof
|
|
EP2970940B1
(en)
|
2013-03-14 |
2018-07-25 |
Translate Bio, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
CN105247075B
(zh)
|
2013-03-15 |
2019-02-15 |
威拉赛特公司 |
用于诊断肺病的生物标记物及其使用方法
|
|
US20140329704A1
(en)
|
2013-03-28 |
2014-11-06 |
President And Fellows Of Harvard College |
Markers for mature beta-cells and methods of using the same
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
KR102234623B1
(ko)
|
2013-05-22 |
2021-04-02 |
알닐람 파마슈티칼스 인코포레이티드 |
Ｔｍｐｒｓｓ6 조성물 및 이의 사용 방법
|
|
WO2014196957A1
(en)
|
2013-06-03 |
2014-12-11 |
Nestec Sa |
Methods for diagnosing chronic valvular disease
|
|
US9574241B2
(en)
|
2013-06-03 |
2017-02-21 |
The Trustees Of Columbia University In The City Of New York |
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T-cell lymphomas
|
|
CN105683379A
(zh)
|
2013-06-17 |
2016-06-15 |
布罗德研究所有限公司 |
用于对有丝分裂后细胞的疾病和障碍进行靶向和建模的系统、方法和组合物的递送、工程化和优化
|
|
RU2716420C2
(ru)
|
2013-06-17 |
2020-03-11 |
Те Брод Инститьют Инк. |
Доставка и применение систем crispr-cas, векторов и композиций для целенаправленного воздействия и терапии в печени
|
|
EP3019186A4
(en)
|
2013-07-12 |
2017-03-29 |
Patrick J. Casey |
Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
US20150079062A1
(en)
|
2013-07-12 |
2015-03-19 |
Patrick J. Casey |
Method for harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
RU2545990C2
(ru)
|
2013-07-16 |
2015-04-10 |
Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы |
Способ дифференциальной диагностики стеатоза печени и стеатогепатита
|
|
ES3032935T3
(en)
|
2013-10-22 |
2025-07-29 |
Translate Bio Inc |
Lipid formulations for delivery of messenger rna
|
|
CN103520724B
(zh)
*
|
2013-10-23 |
2016-05-25 |
江苏美迪森生物医药有限公司 |
Hsd17b13蛋白或其编码基因的抑制剂的新用途
|
|
GB201320061D0
(en)
|
2013-11-13 |
2013-12-25 |
Electrophoretics Ltd |
Materials nad methods for diagnosis and prognosis of liver cancer
|
|
WO2015169971A1
(en)
|
2014-05-09 |
2015-11-12 |
Tangent Reprofiling Limited |
Modulators of androgen synthesis
|
|
EP3155116A4
(en)
|
2014-06-10 |
2017-12-27 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
WO2016004387A1
(en)
|
2014-07-02 |
2016-01-07 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Gene expression signature for cancer prognosis
|
|
WO2016009246A1
(en)
|
2014-07-14 |
2016-01-21 |
Casey Patrick J |
Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
|
WO2016028638A1
(en)
|
2014-08-18 |
2016-02-25 |
Drexel University |
Methods, computer-readable media, and systems for assessing samples and wounds, predicting whether a wound will heal, and monitoring effectiveness of a treatment
|
|
US20170335396A1
(en)
|
2014-11-05 |
2017-11-23 |
Veracyte, Inc. |
Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
|
|
CA2976445A1
(en)
*
|
2015-02-13 |
2016-08-18 |
Alnylam Pharmaceuticals, Inc. |
Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
|
|
CN104698108B
(zh)
|
2015-03-26 |
2016-11-09 |
中国药科大学 |
一种利用固定化酶筛选I型17β羟类固醇脱氢酶抑制剂的方法
|
|
WO2017048620A1
(en)
|
2015-09-14 |
2017-03-23 |
Alnylam Pharmaceuticals, Inc. |
Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (pnpla3) and methods of use thereof
|
|
EP3159407A1
(en)
|
2015-10-23 |
2017-04-26 |
Silence Therapeutics (London) Ltd |
Guide rnas, methods and uses
|
|
EP3387129A1
(en)
|
2015-12-10 |
2018-10-17 |
Alnylam Pharmaceuticals, Inc. |
STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
|
|
EP3390666A4
(en)
|
2015-12-14 |
2019-08-07 |
Cold Spring Harbor Laboratory |
COMPOSITIONS AND METHODS OF TREATING NURSE DISEASES
|
|
JP7049249B2
(ja)
|
2015-12-14 |
2022-04-06 |
コールド スプリング ハーバー ラボラトリー |
中枢神経系疾患の処置のための組成物および方法
|
|
JP7036723B2
(ja)
|
2015-12-14 |
2022-03-15 |
コールド スプリング ハーバー ラボラトリー |
眼疾患の処置のための組成物および方法
|
|
CA3005245A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Antisense oligomers for treatment of alagille syndrome
|
|
EP3390635A4
(en)
|
2015-12-14 |
2019-05-01 |
Cold Spring Harbor Laboratory |
Antisense oligomers for the treatment of a tuberous sclerosis complex
|
|
ES2903394T3
(es)
|
2015-12-14 |
2022-04-01 |
Cold Spring Harbor Laboratory |
Composiciones para el tratamiento de la retinitis pigmentosa 13
|
|
JP2019500345A
(ja)
|
2015-12-14 |
2019-01-10 |
コールド スプリング ハーバー ラボラトリー |
肝臓病の処置のための組成物および方法
|
|
US20190071795A1
(en)
|
2016-03-09 |
2019-03-07 |
Molecular Stethoscope, Inc. |
Methods and systems for detecting tissue conditions
|
|
CA3221950A1
(en)
|
2016-03-16 |
2017-09-21 |
Spogen Biotech Inc. |
Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes
|
|
WO2017191274A2
(en)
|
2016-05-04 |
2017-11-09 |
Curevac Ag |
Rna encoding a therapeutic protein
|
|
US10036024B2
(en)
|
2016-06-03 |
2018-07-31 |
Purdue Research Foundation |
siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
|
|
GB201609977D0
(en)
|
2016-06-08 |
2016-07-20 |
Cancer Rec Tech Ltd |
Chemosensitivity predictive biomarkers
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
TWI788312B
(zh)
*
|
2016-11-23 |
2023-01-01 |
美商阿尼拉製藥公司 |
絲胺酸蛋白酶抑制因子Ａ１ ｉＲＮＡ組成物及其使用方法
|
|
SG10202106058WA
(en)
|
2016-12-08 |
2021-07-29 |
Intellia Therapeutics Inc |
Modified guide rnas
|
|
AU2017374042C1
(en)
|
2016-12-09 |
2024-07-11 |
Acuitas Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
AU2017378427A1
(en)
|
2016-12-14 |
2019-06-20 |
Ligandal, Inc. |
Methods and compositions for nucleic acid and protein payload delivery
|
|
RU2019126483A
(ru)
|
2017-01-23 |
2021-02-24 |
Ридженерон Фармасьютикалз, Инк. |
Варианты 17-бета-гидроксистероиддегидрогеназы 13 (hsd17b13) и их применение
|
|
CN118581154A
(zh)
|
2017-06-02 |
2024-09-03 |
国家健康与医学研究院 |
用于遗传障碍的基因疗法的基因组编辑手段和结合病毒载体的基因疗法
|
|
AU2018348195B2
(en)
|
2017-10-11 |
2025-05-15 |
Regeneron Pharmaceuticals, Inc. |
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
|
|
AU2019239971B2
(en)
|
2018-03-21 |
2025-09-11 |
Regeneron Pharmaceuticals, Inc. |
17beta-hydroxysteroid dehydrogenase type 13 (HSD17b13) iRNA compositions and methods of use thereof
|
|
US20210000906A1
(en)
|
2018-03-21 |
2021-01-07 |
Ionis Pharmaceuticals, Inc. |
Modulation of hsd17b13 expression
|
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
AU2019282824C1
(en)
|
2018-06-08 |
2026-04-23 |
Intellia Therapeutics, Inc. |
Modified guide RNAS for gene editing
|
|
CA3103528A1
(en)
|
2018-06-19 |
2019-12-26 |
The Board Of Regents Of The University Of Texas System |
Lipid nanoparticle compositions for delivery of mrna and long nucleic acids
|
|
KR102769565B1
(ko)
|
2018-09-19 |
2025-02-20 |
애로우헤드 파마슈티컬스 인코포레이티드 |
17베타-HSD 유형 13- (HSD17B13)의 발현을 억제하기 위한 RNAi 작용제, 그의 조성물, 및 사용 방법
|
|
CN115135765A
(zh)
*
|
2019-11-08 |
2022-09-30 |
菲奥医药公司 |
用于免疫治疗的靶向含布罗莫结构域之蛋白4(brd4)的经化学修饰的寡核苷酸
|
|
EP4110919A4
(en)
*
|
2020-02-28 |
2024-06-05 |
Ionis Pharmaceuticals, Inc. |
COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION
|
|
JP2023547512A
(ja)
*
|
2020-11-04 |
2023-11-10 |
ウニベルジテート ベルン |
細胞におけるｐｒｏｓ１の発現を阻害するための核酸
|